Alphatec Holdings (ATEC) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Alphatec Holdings | 1.15 Bn | 1.01 Bn | 136.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.16% |
| Dec 31, 2025 | 4.10% |
| Sep 30, 2025 | -12.77% |
| Jun 30, 2025 | -21.09% |
| Mar 31, 2025 | -20.16% |
| Dec 31, 2024 | -461.01% |
| Sep 30, 2024 | -340.08% |
| Jun 30, 2024 | -323.11% |
| Mar 31, 2024 | -292.59% |
| Dec 31, 2023 | -295.06% |
| Sep 30, 2023 | -299.34% |
| Jun 30, 2023 | -432.50% |
| Mar 31, 2023 | -270.92% |
| Dec 31, 2022 | -74.34% |
| Sep 30, 2022 | -259.82% |
| Jun 30, 2022 | -252.68% |
| Mar 31, 2022 | -242.06% |
| Dec 31, 2021 | -54.46% |
| Sep 30, 2021 | -63.72% |
| Jun 30, 2021 | -62.96% |
| Mar 31, 2021 | -57.42% |
| Dec 31, 2020 | -50.76% |
| Sep 30, 2020 | -36.83% |
| Jun 30, 2020 | -131.88% |
| Mar 31, 2020 | -84.74% |
| Dec 31, 2019 | -78.40% |
| Sep 30, 2019 | 62.03% |
| Jun 30, 2019 | 59.90% |
| Mar 31, 2019 | 62.13% |
| Dec 31, 2018 | 75.72% |
| Sep 30, 2018 | 68.93% |
| Jun 30, 2018 | 69.65% |
| Mar 31, 2018 | 52.81% |
| Dec 31, 2017 | 19.73% |
| Sep 30, 2017 | 52.30% |
| Jun 30, 2017 | 59.67% |
| Mar 31, 2017 | 40.89% |
| Dec 31, 2016 | 18.72% |
| Sep 30, 2016 | -22.91% |
| Jun 30, 2016 | -1.78% |
| Mar 31, 2016 | -4.88% |
| Jun 30, 2015 | 14.78% |